BioRestorative Therapies reincorporates from Delaware to Nevada as of Dec 31, 2022

BioRestorative Therapies, Inc.

Reincorporation approved by stockholders on Nov 3, 2022; effective Dec 31, 2022 via merger of DE corp into NV subsidiary.
Each outstanding share of common and Series B preferred converted 1:1 into Nevada corporation shares.
Outstanding options, warrants, restricted stock, and equity plans assumed by Nevada corporation on identical terms.
Directors and officers unchanged; no change in business, headquarters, assets, or liabilities.
Stockholder rights modified under Nevada law vs. Delaware; details in Sept 23, 2022 proxy statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.